The mechanism of carbamazepine aggravation of absence seizures.
about
Understanding ictogenesis in generalized epilepsies.Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsyRisk factors and the outcome of therapy in patients with seizure after Carbamazepine poisoning: A two-year cross-sectional study.Cellular and network mechanisms of genetically-determined absence seizures.Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome.Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.Augmented currents of an HCN2 variant in patients with febrile seizure syndromesCurrent and emerging treatments for absence seizures in young patientsEvaluating whole genome sequence data from the Genetic Absence Epilepsy Rat from Strasbourg and its related non-epileptic strain.Seizure aggravation-evidence that oxcarbazepine requires monitoring.Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.[Evolution of electro clinical syndromes in dizygotic twins: from childhood to adolescence, about an observation].Multi-electrode array study of neuronal cultures expressing nicotinic β2-V287L subunits, linked to autosomal dominant nocturnal frontal lobe epilepsy. An in vitro model of spontaneous epilepsy.Increased thalamic inhibition in the absence seizure prone DBA/2J mouse.T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures.Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.Acute effect of carbamazepine on corticothalamic 5-9-Hz and thalamocortical spindle (10-16-Hz) oscillations in the rat.Network-specific mechanisms may explain the paradoxical effects of carbamazepine and phenytoin.Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model.Quantitative bioanalytical and analytical method development of dibenzazepine derivative, carbamazepine: A review.Carbamazepine reduces the behavioural manifestations of tinnitus following salicylate treatment in rats.A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities
P2860
Q30827533-8149100A-6C55-48CF-AA7F-A9F9D45CEA0FQ31139176-884207FE-E0FF-4E8E-B2D6-4E5FD8AC14B8Q35080709-DEC439AD-C022-40E7-AFA7-09202B4EFB27Q35199746-C9810C41-BFE3-48DD-974A-298781F08649Q35567225-93D28187-001F-44FA-86A5-D6B39CB8CF83Q35664957-BD706284-8EC8-4D71-9C9F-60140C4A74DFQ36057848-343A16AA-30E0-430B-9C58-3CD74075F69DQ38124030-5E63126E-7EA5-4320-AE9C-C670B6EFC4B7Q38678852-3615DA8A-A25C-499E-B741-78D2B822037CQ39643025-5330B3CE-8152-4EC6-9DF6-8FBFE9463474Q39646371-061A6BA2-7DCE-4B62-A6CC-92870B79B7C5Q41448148-70B86FCE-87AE-4F8F-82C5-B0C169CF552FQ42025172-4284474E-A933-4886-A6B0-97D8677C5205Q42174253-EFC5832D-1B9A-4A4E-97DC-BE87FB2D4CD6Q42721175-6FA85F9C-0B6D-450E-A1DF-CE2D78C5DC83Q44829751-13D61318-BB05-4F70-BDD3-399E1BF1159DQ45523745-335C3C87-7806-4635-ACF3-D606F9A39163Q48092058-FCE01E1A-864D-4002-812B-150A141992F9Q48419190-E0D993FA-D7BD-4986-A2B5-D0206FD8C7C1Q48727007-C4185575-5710-4354-BBE6-1A640F58716CQ49215698-DAF1C17E-3C56-4319-8CB4-4D891DB5FE1BQ50888371-99860853-5BBA-4AB7-9A73-47788BFE7CFDQ55315340-17120932-4C9D-4A96-B0F4-3C337A107335
P2860
The mechanism of carbamazepine aggravation of absence seizures.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The mechanism of carbamazepine aggravation of absence seizures.
@ast
The mechanism of carbamazepine aggravation of absence seizures.
@en
The mechanism of carbamazepine aggravation of absence seizures.
@nl
type
label
The mechanism of carbamazepine aggravation of absence seizures.
@ast
The mechanism of carbamazepine aggravation of absence seizures.
@en
The mechanism of carbamazepine aggravation of absence seizures.
@nl
prefLabel
The mechanism of carbamazepine aggravation of absence seizures.
@ast
The mechanism of carbamazepine aggravation of absence seizures.
@en
The mechanism of carbamazepine aggravation of absence seizures.
@nl
P2093
P356
P1476
The mechanism of carbamazepine aggravation of absence seizures
@en
P2093
Alison L Clarke
Charlott Wallengren
Margaret J Morris
Steven Petrou
Thomas Zheng
P304
P356
10.1124/JPET.106.104968
P407
P577
2006-08-08T00:00:00Z